Brief: Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

CDT Equity

21/11/2024 12:33

Nov 21 (Reuters) - Conduit Pharmaceuticals Inc  CDT.O :
    * CONDUIT PHARMACEUTICALS RECEIVES FURTHER PATENT APPROVAL
FOR
LEAD ASSET TARGETING AUTOIMMUNE DISORDERS

Source text:  ID:nGNX4VhMLN 
Further company coverage:  CDT.O 

 ((Reuters.Briefs@thomsonreuters.com;))